Valproic acid monotherapy induces DNA oxidative damage

Toxicology

Volumn 217, Issue 2-3, 2006, Pages 228-232

  Schulpis, Kleopatra H ^a   Lazaropoulou, Christina ^b   Regoutas, Spyros ^b   Karikas, George A ^b   Margeli, Alexandra ^b   Tsakiris, Stylianos ^c   Papassotiriou, Ioannis ^b  

^a Athens Technology Center   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

8 OHdG; Free radicals; Valproic acid

Indexed keywords

DEOXYGUANOSINE DERIVATIVE; FREE RADICAL; VALPROIC ACID;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DNA DAMAGE; DRUG BLOOD LEVEL; FOLLOW UP; HUMAN; LIPID ANALYSIS; LIVER FUNCTION TEST; MONOTHERAPY; OXIDATIVE STRESS; PRIORITY JOURNAL; SEIZURE;

ANTICONVULSANTS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DEOXYGUANOSINE; DNA DAMAGE; HUMANS; LIPID PEROXIDATION; LIVER; LIVER FUNCTION TESTS; OXIDANTS; OXIDATIVE STRESS; SEIZURES; TREATMENT OUTCOME; VALPROIC ACID;

TOSCANA VIRUS;

EID: 28844466046     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2005.10.004     Document Type: Article

References (32)

1. A.E. Bryan, and F.E. Dreifuss Valproic acid hepatic fatalities III US experience since Neurology 46 1996 465 469
2. J.R. Calabrese, and G.A. Delucchi Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorders Am. J. Psychiatry 147 1990 431 434
3. M. Cengiz, A. Yukcel, and M. Seven The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children Pharmacol. Res. 41 2000 423 425
4. M. Cobb, and S. Gother Fluorescence immunoassay in the clinical laboratory Am. J. Med. Tech. 48 1982 671 677
5. D. Cotariu, S. Evans, E. Lahat, J. Theitler, T. Bistrizer, and J.L. Zaidman Inhibition of human red blood cell glutathione reductase by valproic acid Biochem. Pharmacol. 43 1992 425 429
6. T. Finker, and N.J. Holbrook Oxidants, oxidative stress and the biology of aging Nature (London) 408 2000 239 247
7. R. Fisher, H. Nau, A.J. Gantolphy, C.W. Putnann, and K. Bredel Valproic acid hepatotoxicity in human liver slices Drug Chem. Toxicol. 14 1991 375 394
8. Y. Gilgun-Sherki, Z. Rosenbaum, E. Melamed, and D. Offen Antioxidant therapy in acute central nervous system injury Curr. State Pharmacol. Rev. 54 2000 271 284
9. 2 chemosensitivity Blood 99 2002 1552 1555
10. M. Ichiba, Y. Maeta, T. Mukoyama, T. Sacki, S. Yasui, T. Kanbe, J. Okano, Y. Tanabe, Y. Hirroka, S. Yamada, A. Kurinasa, Y. Murawaki, and G. Shiota Expression of 8-hydroxy-2-deoxyguanosine in chronic liver disease and hepatocellular carcinoma Liver Int. 23 2003 338 345
11. T. Inoue, K. Inoue, H. Maeda, K. Takayanagi, and S. Morroka Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL concentrations in dyslipidemic patients Clin. Chim. Acta 305 2000 115 121
12. P.M. Jeavons Non-dose-related side effects of valproate. Epilepsia 25 1984 550 556
13. J.A. Jesberger, and J.S. Richardson Oxygen free radicals and brain dysfunction Int. J. Neurosci. 57 1991 1 17
14. H. Kasai, P.F. Crain, Y. Kuchino, S. Nishimura, A. Ootsuyama, and H. Tonooka Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair Carcinogenesis 7 1986 1849 1851
15. E. Lepkifker, I.D.P. Iancu, R. Ziv, and M. Kotler Valproic acid in ultra-rapid cycling Clin. Neuropharmacol. 18 1995 72 75
16. P. Maertens, R. Dyken, and W. Graf Free radicals, anticonvulsants, and the neuronal ceroid lipofuscinoses Am. J. Med. Genet. 57 1995 225 228
17. D.C. Marchion, E. Bicacu, Al. Dand, D.M. Sullivan, and P.N. Munster Valproic acid alters chromatin structure by regulation of chromatin modulation proteins Cancer Res. 65 2005 3815 3822
18. C. Martinez-Ballesteros, E. Pita-Calandre, Y. Sanchez-Gonzalez, C.M. Rodreiguez-Lopez, and A. Agil Lipid peroxidation in adult epileptic patients with valproic acid Rev. Neurol. 38 2004 101 106
19. M.J. Miller, C. Rice-Evans, M.J. Davies, V. Copinathan, and A. Milner A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates Clin. Soc. (Colch) 84 1993 407 412
20. H. Nau, and H.J. Loscher Valproic acid and metabolites: pharmacological and toxicological studies Epilepsia 25 Suppl. 1 1989 514 522
21. Physicians Desk Reference, 1999. Sodium Valproate, 53rd ed. Montral, NJ, pp. 417-419.
22. C.E. Pippenger, X. Meng, F. Van Lente, and A.D. Rotliner Valproate therapy depressed GSHpX and SOD enzyme activity. A possible mechanism for valproate induced idiosyncratic drug toxicity Clin. Chem. 35 1989 1173
23. C. Richter, J.W. Park, and B.N. Ames Normal oxidative damage to mitochondrial and nuclear DNA is extensive Proc. Natl. Acad. Sci. U.S.A. 85 1988 6467 6565
24. C.E. Shelton, and J.F. Connelly Valproic acid: a migraine prophylaxis alternative Ann. Pharmacother. 30 1996 865 866
25. M. Strube, G.R. Haenen, H. Van der Berg, and A. Bast Pitfalls in a method for assessment of total antioxidant capacity Free Radic. Res. 26 1997 515 521
26. A.R. Tabatabaei, and F.R. Abbott Assessing the mechanism of metabolism dependent valproic acid induced in vitro cytotoxicity Chem. Res. Toxicol. 12 1999 323 330
27. A.R. Tabatabaei, R.L. Thies, K. Farrell, and F.S. Abbott A rapid in vitro assay for evaluation of metabolism dependent cytotoxicity of antiepileptic drug on isolated human lymphocytes Foundam. Appl. Toxicol. 37 1997 181 189
28. V. Tong, T.K. Chang, J. Chen, and F.S. Abbot The effect of valproic acid on hepatic and plasma levels of 15-F2t-isoprostane in rats Free Radic. Biol. Med. 34 2003 1435 1446
29. D. Torbati, D.F. Church, J.M. Keller, and W. Pryor Free radical generation in the brain precedes hyperbaric oxygen induced convulsions Free Radic. Biol. Med. 13 1992 101 106
30. K. Yaki Lipid peroxides and related radicals in clinical medicine D. Armistrong Free Radicals in Diagnostic Medicine 1999 Plenum Press New York 1 14
31. B. Yin, R.M. Whyatt, F.P. Perera, M.C. Randal, T.B. Cooper, and R.M. Santella Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody based ELISA Free Radic. Biol. Med. 18 1995 1023 1032
32. H.J. Ziemmerman, and K.G. Ishak Valproate induced hepatic injury: analyses of 23 fatal cases Hepatology 2 1982 591 597